Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Factors affecting posaconazole blood concentration in hematologic malignancy patients
ChiCTR2100045800Phase 4Recruiting
- Sponsor
- The First Hospital of Hebei Medical University
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of posaconazole in mycoses and invasive mycoses (2 arms), sponsored by The First Hospital of Hebei Medical University. Primary endpoint: Posaconazole blood concentration. Started Jun 2020; status: recruiting.
02
Drugs
posaconazole
03
Conditions
mycosesinvasive mycoses
Beyond the preview
Go deeper on ChiCTR2100045800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045800.